// App-Quantinova.ai

TCT-14 : A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) After PCI in Brazil and Japan: SYNERGY Stent With Prasugrel Monotherapy (10 mg or 3.75 mg)

Researchers

Presenter

  • Yoshinobu Onuma

Principal Investigators

  • Takashi Muramatsu

  • Ken Kozuma

  • Yuki Ishibashi

  • Kuniaki Takahashi

  • Kengo Tanabe

  • Norihiro Kogame

  • Masato Nakamura

  • Taku Asano

  • Yosuke Miyazaki

  • Shimpei Nakatani

  • Yuki Katagiri

  • Yoshihiro Morino

  • Shinichiro Masuda

  • Kai Ninomiya

  • Shigetaka Kageyama

  • Nozomi Kotoku

  • Patrick Serruys

Medical Centers

  • Fujita Health University School of Medicine, Aichi, Japan

  • Yamaguchi University, Ube, Japan

  • Sapporo Higashi Tokushukai Hospital, Sapporo, Japan

  • Saitama Medical University Hospital, Moroyama, Japan

  • Toho University Ohashi Medical Center, Tokyo, Japan

  • Stmarianna University, Kawasaki, Japan

  • Mitsui Memorial Hospital, Tokyo, Japan

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • National University of Ireland, Galway, Ireland

  • St.Luke's International Hospital, Tokyo, Japan

Locations

  • Japan

  • Netherlands

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Prasugrel

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A